DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
Yingshan ChenYongxuan YaoKaitao ZhaoCanyu LiuYifei YuanHao SunDan HuangYi ZhengYuan ZhouJi-Zheng ChenYun WangChunchen WuBixiang ZhangYujuan GuanFeng LiRongjuan PeiXinwen ChenPublished in: Journal of virology (2022)
The biogenesis of covalently closed circular DNA (cccDNA) from relaxed circular DNA (rcDNA) is essential for chronic hepatitis B virus (HBV) infection. Different host DNA repair proteins are involved in the conversion of rcDNA to cccDNA. Here, we reported that the DNA repair factor poly(ADP-ribose) polymerase 1 (PARP1) is engaged in HBV cccDNA formation. PARP1 depletion remarkably impaired HBV replication and cccDNA synthesis. Inhibition of PARP1 poly (ADP-ribosylation) activity by olaparib suppressed cccDNA synthesis both in vitro and in vivo . Specifically, the early stage of cccDNA reservoir establishment was more sensitive to olaparib, suggesting that PARP1 participated in de novo cccDNA formation. Furthermore, PARP1 was activated by recognizing the rcDNA-like lesions directly and combined with other DNA repair proteins. The results presented proposed that the DNA damage-sensing protein PARP1 and poly(ADP-ribosylation) modification play a key role in cccDNA formation, which might be the target for developing the anti-HBV drug. IMPORTANCE The biogenesis and eradication of HBV cccDNA have been a research priority in recent years. In this study, we identified the DNA repair factor PARP1 as a host factor required for the HBV de novo cccDNA formation. HBV infection caused PARylation through PARP1 in Huh7-NTCP cells, primary human hepatocytes, and human-liver chimeric mice. We found that PARP1 could directly bind to the rcDNA lesions and was activated, PARylating other DNA repair proteins. We address the importance of PARP1-mediated PARylation in HBV cccDNA formation, which is a potential therapeutic target for chronic hepatitis B.
Keyphrases
- dna repair
- hepatitis b virus
- dna damage
- liver failure
- dna damage response
- early stage
- oxidative stress
- circulating tumor
- radiation therapy
- metabolic syndrome
- endothelial cells
- induced apoptosis
- type diabetes
- stem cells
- lymph node
- emergency department
- cell therapy
- cell proliferation
- bone marrow
- endoplasmic reticulum stress
- mesenchymal stem cells
- liver fibrosis
- adverse drug
- skeletal muscle